HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
2.000
-0.010 (-0.50%)
Apr 28, 2026, 4:00 PM EDT - Market closed
HeartSciences Ratios and Metrics
Market cap in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 |
| Market Capitalization | 6 | 4 | 6 | 9 | - | - | |
| Market Cap Growth | 70.87% | -37.46% | -29.92% | - | - | - | |
| Enterprise Value | 7 | 4 | 0 | 8 | - | - | |
| Last Close Price | 2.00 | 3.50 | 9.24 | 88.75 | - | - | |
| PS Ratio | 735.05 | 870.97 | 325.69 | 1678.48 | - | - | |
| PB Ratio | 2.40 | 18.47 | 0.83 | 37.49 | - | - | |
| P/TBV Ratio | 11.87 | - | 1.06 | 37.56 | - | - | |
| EV/Sales Ratio | 789.28 | 960.84 | 2.20 | 1629.68 | - | - | |
| Debt / Equity Ratio | 1.46 | 14.55 | 0.14 | 6.79 | -1.02 | -1.61 | |
| Net Debt / Equity Ratio | 0.18 | 9.20 | -0.65 | -0.41 | -0.87 | -1.23 | |
| Net Debt / EBITDA Ratio | -0.06 | -0.23 | 0.76 | 0.02 | -1.12 | -0.93 | |
| Net Debt / FCF Ratio | -0.06 | -0.25 | 0.78 | 0.02 | -1.44 | -0.96 | |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | |
| Inventory Turnover | 0.01 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | |
| Quick Ratio | 0.80 | 0.30 | 3.32 | 0.91 | 0.27 | 0.65 | |
| Current Ratio | 1.19 | 0.59 | 4.20 | 1.47 | 0.56 | 1.47 | |
| Return on Equity (ROE) | -382.32% | -233.04% | -175.02% | - | - | - | |
| Return on Assets (ROA) | -73.51% | -76.06% | -61.63% | -142.12% | -146.55% | -82.67% | |
| Return on Capital Employed (ROCE) | -237.30% | -1607.20% | -81.40% | -420.30% | 341.00% | -315.60% | |
| Earnings Yield | -133.16% | -231.35% | -109.03% | -73.51% | - | - | |
| FCF Yield | -115.26% | -195.74% | -101.27% | -67.00% | - | - | |
| Buyback Yield / Dilution | -152.81% | -166.16% | -343.39% | -139.56% | -0.15% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.